Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results


1.		Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 85				Other				06-14034 NCT00628784

Last Modified: 10/9/2008 First Published: 11/24/2002


2.		Phase III Randomized Study of Adjuvant Chemoradiation After Resection in Patients With Gastric or Gastroesophageal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-80101 NCCTG-CALGB-80101, ECOG-CALGB-80101, CALGB-80101, NCT00052910


3.		Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 to 82				Other				Pro00002207 SPS 151596, NCT00578071


4.		Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				SCRI GI 91 AVF3921s, NCT00393068

Last Modified: 5/20/2008 First Published: 8/29/2007


5.		Phase II Study of Erlotinib Hydrochloride and Radiotherapy in Older Patients With Stage I-IV Squamous Cell Carcinoma or Adenocarcinoma of the Esophagus or Gastroesophageal Junction

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Over 65				NCI				RPCI-I-62705 I 62705, NCT00524121


6.		Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				BrUOG-E-215 NCT00522795


7.		Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 75				Other				UMCC 2006.117 NCT00570531

Last Modified: 9/15/2008 First Published: 7/3/2008


8.		Phase II Study of Neoadjuvant Capecitabine, Oxaliplatin, and Radiotherapy in Patients With Adenocarcinoma of the Esophagus or Gastroesophageal Junction

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				NU-0512 NU 05I2, NU-IRB-0948-009, NCT00711412


9.		Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Active				18 and over				Other				99-0522 NCT00260559


10.		Chemoradiation-Induced Nausea and Emesis: Quality of Life

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Natural history/Epidemiology, Treatment				Active				18 and over				Other				2003-0529 NCT00394602

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute